Last Friday, the FDA approved the SGLT2 inhibitor dapaglifozin. This is the second drug in the SGLT2-I class and so now the battle of superiority, dapagliflozin versus canagliflozin, begins. There will also be extra pressure from the DPP4-I companies to downplay the value of this drug class. This week, in …
Read More »Monthly Archives: January 2014
Therapy of Type 2 Diabetes Mellitus, Update, Part 7
In this week’s Homerun Slides from Dr. Stanley Schwartz, we continue our discussion of medications, including the SGLT2 inhibitor canagliflozin and the central dopamine agonist bromocriptine. We then begin to delve into therapy for type 2 diabetes, targets for glycemic control, and targeting postprandial glucose….
Read More »Diabetes Clinical Case Series, Excerpt #6, Endocrinology and Diabetes
Ramzi Ajjan, MRCP, Med Sci, PhD Acute confusion in an 82-year-old with known type 2 diabetes Brian, an 82-year-old gentleman with known type 2 diabetes, is brought to A&E with general deterioration and acute confusion. What differential diagnoses would you consider and what would you do?…
Read More »Letter from the Editor, #711: CES, Forxiga, and Keeping New Year’s Resolutions
I am at the annual Consumer Electronics Show in Las Vegas this week and it is easy to see how technology is moving into the healthcare segment. Three years ago, less than 2% of the booths were dedicated to health and wellness — this year, a full 30% of them …
Read More »Achieving Lasting Adoption of Lifestyle Changes
Learning to overcome barriers that interfere with a more physically active lifestyle is a critical part of effective diabetes self-management, especially when health complications like neuropathy, nephropathy, and retinopathy make being active more challenging1.
Read More »FDA Approves New Diabetes Drug
FDA Approves New Diabetes Drug. See this week’s Item #1. Truebalance and Truetrack Blood Glucose Meters by Nipro Diagnostics: Recall – Incorrect Factory-set Measure. Meters have an incorrect factory-set unit of measure that displays the glucose result in mmol/L rather than mg/dl. www.NiproDiagnostics.com/product-notice
Read More »Retina Camera
Retina Camera A new optical device the size of a hand held video camera from the Massachusetts Institute of Technology can scan an entire retina in seconds. This device combines ultra high-speed 3D imaging, a tiny micro-electro mechanical systems mirror for scanning, and corrective techniques for unintentional movements in a …
Read More »Universal Food Diary
Universal Food Diary Here is a very basic one page food diary from dLife all your patients can use. Have them fill it out prior to their appointment. Having your patients write down their daily food intake can have a huge impact on their blood sugars. Food Diary(pdf)
Read More »Asthma Drug to Treat Diabetes and Obesity
Obese mice treated with the asthma drug amlexanox had a renewed sensitivity to catecholamines, utilized excess energy, and returned to normal size, according to Alan R. Saltiel, PhD, University of Michigan. "There is considerable evidence to suggest that in states of obesity, adipose tissue becomes less sensitive to catecholamines because …
Read More »Prostate Cancer Death Risk Higher with Diabetes
A team led by Laurent Azoulay, MD, of McGill University in Montreal, studied 11,920 men newly diagnosed with non-metastatic prostate cancer (PCa). The cohort included 1,132 men (9.5%) with pre-existing type 2 diabetes. A total of 3,605 deaths, including 1,792 from PCa, occurred during a mean 4.7 years of follow-up. …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.